Home > Insider Trading > Filing (0001140361-17-030844)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561387	Health Insurance Innovations Inc.	HIIQ	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1366007	Bruce Telkamp	C/O Health Insurance Innovations, Inc. 15438 N. Florida Ave., Suite 201 Tampa FL 33613	Ceo Of Healthpocket, Inc.*	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Disposition	2017-08-07	11,501	$31.45	17,500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Stock Appreciation Rights	$12.13		2021-07-14	6,000	6,000	Direct
Class A Common Stock	Stock Appreciation Rights	$4.95		2022-07-01	30,000	30,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-07-14	6,000	6,000	Direct
2022-07-01	30,000	30,000	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2017.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.95 to $31.95, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations Inc., any security holder of Health Insurance Innovations Inc., or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
These stock-settled stock appreciation rights were previously granted under the Issuer's Long Term Incentive Plan, as amended ("Plan"), and are scheduled to vest in increments of 20%, 20%, 20% and 40% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.
These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.